Recursion Pharmaceuticals, Inc 10-K for FY2025
Recursion Pharmaceuticals, Inc. (RXRX)
10-K
2026-02-25
For: 2025-12-31
View Original
Added on
April 10, 2026
About this 10-K
Recursion Pharmaceuticals, Inc filed this 10-K on February 25, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $74.68M
- up 26.9% from $58.84M a year earlier
- Net loss
- $644.76M
- compared with a net loss of $463.66M a year earlier
- Diluted EPS
- -$1.44
- compared with -$1.69 a year earlier